(2026). Cost-effectiveness of semaglutide versus dulaglutide for Type 2 Diabetes in China: A Markov Model analysis. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Cost-effectiveness of Semaglutide Versus Dulaglutide for Type 2 Diabetes in China: A Markov Model Analysis."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Cost-effectiveness of Semaglutide Versus Dulaglutide for Type 2 Diabetes in China: A Markov Model Analysis."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.